BIOXAPARIN
Live / Applied — Statement of use — non-final action mailed (as of 29 Apr 2026)
What this means for you
Not registered yet, but its 23 Sept 2024 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98765145
- Mark type
- Word mark
- Filed
- 23 Sept 2024
- Published for opposition
- 15 Apr 2025
- Attorney of record
- Michael F. Swartz
Goods and services
- Class 005 — Pharmaceuticals: Anticoagulants; Pharmaceutical preparations, namely, anticoagulants
Owner
- SCIENCE AI CORPORATION, San Francisco, CA, US
- SCIENCE AI CORPORATION, San Francisco, CA, US
Prosecution history
- 29 Jul 2026 — APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
- 29 Jul 2026 — APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
- 29 Apr 2026 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 29 Apr 2026 — NON-FINAL ACTION E-MAILED
- 29 Apr 2026 — SU - NON-FINAL ACTION - WRITTEN
- 14 Apr 2026 — STATEMENT OF USE PROCESSING COMPLETE
- 07 Nov 2025 — USE AMENDMENT FILED
- 07 Nov 2025 — TEAS STATEMENT OF USE RECEIVED
- 10 Jun 2025 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 15 Apr 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 15 Apr 2025 — PUBLISHED FOR OPPOSITION
- 09 Apr 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 19 Mar 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 18 Mar 2025 — ASSIGNED TO EXAMINER
- 23 Sept 2024 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED